Gwajin asibiti

Babu wani sabon induras da aka lura a cikin ƙungiyar NIF idan aka kwatanta da IP.(P=0.0150) An lura da allurar karya a cikin rukunin IP, babu haɗari a cikin ƙungiyar NIF.Matsakaicin ma'anar da aka daidaita daga asali na HbA1c 0.55% a mako na 16 a cikin rukunin NFI ba shi da ƙasa da ƙididdigewa idan aka kwatanta da na 0.26% a rukunin IP.Gudanar da insulin ta NIF zai iya samar da ingantaccen bayanin martabar aminci fiye da ta alluran IP, ta hanyar rage ɓarkewar fata, rashin jin daɗi, zafi kuma babu haɗarin fashewar allura.

Gabatarwa:

Adadin marasa lafiya da ke da nau'in ciwon sukari na 2 ta amfani da insulin har yanzu yana da ƙasa sosai kuma galibi ana farawa da ɗan lokaci kaɗan.An gano abubuwa da yawa da suka shafi jinkirin amfani da insulin, ciki har da tsoron allura, rikice-rikice na tunani a lokacin allurar insulin da rashin jin daɗin allurar insulin, duk waɗannan dalilai ne masu mahimmanci ga marasa lafiya da suka ƙi fara maganin insulin.Bugu da ƙari, rikice-rikicen allura kamar rashin jin daɗi da ke haifar da sake amfani da allura na dogon lokaci kuma na iya shafar ingancin jiyya na insulin a cikin marasa lafiya waɗanda suka riga sun yi amfani da insulin.

An tsara allurar insulin mara allura don masu ciwon sukari waɗanda ke tsoron allura ko kuma ba su son fara maganin insulin lokacin da aka nuna shi a fili.Wannan binciken ya yi niyya don kimanta gamsuwar haƙuri da yarda da allurar insulin mara allura tare da allurar alƙalamin insulin na al'ada a cikin marasa lafiya tare da T2DM da aka yi wa magani na makonni 16.

Hanyoyin:

Jimlar marasa lafiya 427 tare da T2DM an sanya su a cikin cibiyar da yawa, mai yiwuwa, bazuwar, binciken alamar buɗaɗɗen, kuma an bazu 1: 1 don karɓar insulin basal ko insulin premixed ta hanyar allura mara allura ko ta allurar alkalami na al'ada.

Sakamako:

A cikin marasa lafiya 412 da suka kammala binciken, ma'anar ƙididdigar tambayoyin SF-36 sun karu sosai a cikin allura marasa allura da ƙungiyoyin alkalami na insulin na al'ada, ba tare da wani babban bambanci tsakanin ƙungiyoyin cikin yarda ba.Koyaya, batutuwa a cikin rukunin masu allura marasa allura sun nuna ƙimar gamsuwar jiyya fiye da waɗanda ke cikin rukunin alƙalamin insulin na al'ada bayan makonni 16 na jiyya.

Taƙaice:

Babu wani muhimmin bambanci tsakanin alkalami na insulin da ƙungiyoyin allura marasa allura akan wannan sakamakon SF-36.

Insulin ba tare da allura ba yana haifar da gamsuwa ga majiyyaci da ingantaccen yarda da magani.

Ƙarshe:

Mai allura mara allura ya inganta rayuwar marasa lafiya T2DM kuma ya inganta gamsuwarsu da jiyya na insulin idan aka kwatanta da allurar alkalami na al'ada.